Live from the NIH registry
Studies recruiting near St. Louis right now
Top 25 of 1,509 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Washington University - St Louis — St Louis, Missouri (2.6 mi)
· Sponsor: University of Michigan
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Washington University School of Medicine (Adults only) — St Louis, Missouri (2.6 mi)
· Sponsor: Pierre Fabre Medicament
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mercy Infusion Center - Chippewa — St Louis, Missouri (2.6 mi)
· Sponsor: SWOG Cancer Research Network
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Viral Infection, Primary Immune Deficiency Disorder
Phase 1, Phase 2
Interventional 40 participants sought
Washington University — St Louis, Missouri (2.6 mi)
· Sponsor: New York Medical College
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Syndax Pharmaceuticals
Decreasing Emergence Agitation With Personalized Music
Surgical Procedure, Unspecified
N/A
Interventional 100 participants sought
Washington University — St Louis, Missouri (2.6 mi)
· Sponsor: Stanford University
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
St. Louis Children's Hospital — St Louis, Missouri (2.6 mi)
· Sponsor: Nationwide Children's Hospital
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: National Cancer Institute (NCI)
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
Spinal Cord Injury, Pressure Injury
N/A
Interventional 808 participants sought
St. Louis VA Medical Center John Cochran Division, St. Louis, MO — St Louis, Missouri (2.6 mi)
· Sponsor: VA Office of Research and Development
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Lung Cancer, Cancer of the Lung
N/A
Observational 279 participants sought
Barnes-Jewish Hospital West County — Creve Coeur, Missouri (9.7 mi)
· Sponsor: Washington University School of Medicine
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
521 — St Louis, Missouri (2.6 mi)
· Sponsor: Corcept Therapeutics
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
Phase 1, Phase 2
Interventional 50 participants sought
H03- Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Cartesian Therapeutics
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Epithelioid Hemangioendothelioma (EHE)
Phase 2
Interventional 41 participants sought
Washington University St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: Sarcoma Alliance for Research through Collaboration
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: RAI Services Company
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Saint Louis University Cancer Center /ID# 260722 — St Louis, Missouri (2.6 mi)
· Sponsor: AbbVie
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Kartos Therapeutics, Inc.
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — St Louis, Missouri (2.6 mi)
· Sponsor: AstraZeneca
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
HSHS St. Elizabeths Hospital — O'Fallon, Illinois (18.3 mi)
· Sponsor: Takeda
IDOV-Immune for Advanced Solid Tumors
Colorectal Cancer, Pancreatic Cancer
Phase 1
Interventional 78 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: ViroMissile, Inc.
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
Missouri Baptist — St Louis, Missouri (2.6 mi)
· Sponsor: NSABP Foundation Inc
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 Mutation, Low-grade Glioma
Phase 2
Interventional 96 participants sought
St. Louis Children's Hospital Washington University in St. Louis — St Louis, Missouri (2.6 mi)
· Sponsor: University of California, San Francisco
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
HNSCC, ESCC
Phase 1
Interventional 150 participants sought
Normunity Investigational Site — St Louis, Missouri (2.6 mi)
· Sponsor: Normunity AccelCo, Inc.
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Rheumatoid Arthritis, Systemic Lupus Erythematosus
Phase 1
Interventional 48 participants sought
Research Site — St Louis, Missouri (2.6 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Washington University School of Medicine — St Louis, Missouri (2.6 mi)
· Sponsor: Bristol-Myers Squibb